Related Experiment Video
Updated: Apr 30, 2026

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
Published on: March 2, 2018
The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit
Ulf Soppa1, Julian Schumacher2, Victoria Florencio Ortiz3
1Institute of Pharmacology and Toxicology; Medical Faculty; RWTH Aachen University; Aachen, Germany; Instituto de Neurociencias; Consejo Superior de Investigaciones Cientificas (CSIC) and Universidad Miguel Hernandez; Alicante, Spain.
Abstract:
A fundamental question in neurobiology is how the balance between proliferation and differentiation of neuronal precursors is maintained to ensure that the proper number of brain neurons is generated. Substantial evidence implicates DYRK1A (dual specificity tyrosine-phosphorylation-regulated kinase 1A) as a candidate gene responsible for altered neuronal development and brain abnormalities in Down syndrome. Recent findings support the hypothesis that DYRK1A is involved in cell cycle control. Nonetheless, how DYRK1A contributes to neuronal cell cycle regulation and thereby affects neurogenesis remains poorly understood. In the present study we have investigated the mechanisms by which DYRK1A affects cell cycle regulation and neuronal differentiation in a human cell model, mouse neurons, and mouse brain. Dependent on its kinase activity and correlated with the dosage of overexpression, DYRK1A blocked proliferation of SH-SY5Y neuroblastoma cells within 24 h and arrested the cells in G₁ phase. Sustained overexpression of DYRK1A induced G₀ cell cycle exit and neuronal differentiation. Furthermore, we provide evidence that DYRK1A modulated protein stability of cell cycle-regulatory proteins. DYRK1A reduced cellular Cyclin D1 levels by phosphorylation on Thr286, which is known to induce proteasomal degradation. In addition, DYRK1A phosphorylated p27(Kip1) on Ser10, resulting in protein stabilization. Inhibition of DYRK1A kinase activity reduced p27(Kip1) Ser10 phosphorylation in cultured hippocampal neurons and in embryonic mouse brain. In aggregate, these results suggest a novel mechanism by which overexpression of DYRK1A may promote premature neuronal differentiation and contribute to altered brain development in Down syndrome.
Insights
Overexpression of DYRK1A kinase blocks neuronal precursor proliferation and promotes differentiation, potentially explaining brain abnormalities in Down syndrome.
Area of Science:
- Neurobiology
- Cell Biology
- Developmental Neuroscience
Background:
- Maintaining the balance between neuronal precursor proliferation and differentiation is crucial for proper brain development.
- DYRK1A (dual specificity tyrosine-phosphorylation-regulated kinase 1A) is implicated in Down syndrome-associated brain abnormalities and may regulate the cell cycle.
Purpose of the Study:
- To investigate the mechanisms by which DYRK1A influences cell cycle regulation and neuronal differentiation.
- To elucidate DYRK1A's role in neurogenesis and its potential contribution to Down syndrome.
Main Methods:
- Utilized a human neuroblastoma cell model (SH-SY5Y), primary mouse neurons, and embryonic mouse brain.
- Investigated the effects of DYRK1A overexpression and kinase inhibition on cell proliferation, cell cycle phase, and protein stability of cell cycle regulators.
Main Results:
- DYRK1A overexpression blocked SH-SY5Y cell proliferation in G₁ phase and induced neuronal differentiation.
- DYRK1A modulated cell cycle protein stability by reducing Cyclin D1 via phosphorylation-induced degradation and stabilizing p27(Kip1) through phosphorylation.
- Inhibition of DYRK1A kinase activity decreased p27(Kip1) phosphorylation in neurons and brain tissue.
Conclusions:
- DYRK1A kinase activity plays a critical role in regulating neuronal cell cycle progression and differentiation.
- Overexpression of DYRK1A may lead to premature neuronal differentiation, contributing to altered brain development observed in Down syndrome.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules

